• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.

作者信息

Zheng Kenneth I, Fan Jian-Gao, Shi Jun-Ping, Wong Vincent Wai-Sun, Eslam Mohammed, George Jacob, Zheng Ming-Hua

机构信息

Department of Hepatology, MAFLD Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 25000, China.

Department of Gastroenterology, Center for Fatty Liver, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai 200065, China.

出版信息

Chin Med J (Engl). 2020 Oct 5;133(19):2271-2273. doi: 10.1097/CM9.0000000000000981.

DOI:10.1097/CM9.0000000000000981
PMID:32701591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7546877/
Abstract
摘要

相似文献

1
From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.从非酒精性脂肪性肝病到代谢相关脂肪性肝病：脂肪性肝病的一个“重新定义”时刻。
Chin Med J (Engl). 2020 Oct 5;133(19):2271-2273. doi: 10.1097/CM9.0000000000000981.
2
From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years.从非酒精性脂肪性肝病（NAFLD）到代谢相关脂肪性肝病（MAFLD）：跨越40年的历程
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):695-696. doi: 10.1016/j.dsx.2020.05.019. Epub 2020 May 13.
3
MAFLD: A holistic view to redefining fatty liver disease.代谢相关脂肪性肝病：重新定义脂肪肝疾病的整体视角
J Hepatol. 2021 Apr;74(4):983-985. doi: 10.1016/j.jhep.2020.12.027. Epub 2021 Jan 13.
4
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease.乳糜泻中的代谢相关脂肪性肝病（MAFLD）
Liver Int. 2021 Apr;41(4):788-798. doi: 10.1111/liv.14767. Epub 2020 Dec 28.
5
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.与非酒精性脂肪性肝病（NAFLD）相比，代谢功能障碍相关脂肪性肝病（MAFLD）能更好地识别出有显著肝纤维化的患者。
Liver Int. 2020 Dec;40(12):3018-3030. doi: 10.1111/liv.14675.
6
Comparison of MAFLD and NAFLD diagnostic criteria in real world.现实世界中MAFLD与NAFLD诊断标准的比较。
Liver Int. 2020 Sep;40(9):2082-2089. doi: 10.1111/liv.14548. Epub 2020 Jul 26.
7
Role of Insulin Resistance in MAFLD.胰岛素抵抗在 MAFLD 中的作用。
Int J Mol Sci. 2021 Apr 16;22(8):4156. doi: 10.3390/ijms22084156.
8
Impact of the New Metabolic-Associated Fatty Liver Disease (MAFLD) on NAFLD Patients Classification in Italy.新型代谢相关脂肪性肝病（MAFLD）对意大利非酒精性脂肪性肝病（NAFLD）患者分类的影响。
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2683-2684. doi: 10.1016/j.cgh.2021.02.015. Epub 2021 Feb 10.
9
MAFLD and risk of CKD.MAFLD 和慢性肾脏病风险。
Metabolism. 2021 Feb;115:154433. doi: 10.1016/j.metabol.2020.154433. Epub 2020 Nov 16.
10
Response to: Comparison of MAFLD and NAFLD diagnostic criteria in real world.对《现实世界中MAFLD与NAFLD诊断标准的比较》的回应
Liver Int. 2020 Dec;40(12):3145. doi: 10.1111/liv.14664.

引用本文的文献

1
Association between the dietary index for gut microbiota and all-cause/cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease.肠道微生物群饮食指数与代谢功能障碍相关脂肪性肝病患者全因/心血管死亡率之间的关联
Diabetol Metab Syndr. 2025 Jul 11;17(1):263. doi: 10.1186/s13098-025-01846-x.
2
Association of diet quality scores with risk of metabolic-associated fatty liver disease in Iranian population: a nested case-control study.伊朗人群饮食质量评分与代谢相关脂肪性肝病风险的关联：一项巢式病例对照研究。
J Diabetes Metab Disord. 2025 Jan 13;24(1):46. doi: 10.1007/s40200-024-01544-x. eCollection 2025 Jun.
3
Elevated thyroid autoantibodies as risk factors for metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus.甲状腺自身抗体升高作为2型糖尿病患者代谢功能障碍相关脂肪性肝病的危险因素
Front Endocrinol (Lausanne). 2024 Dec 5;15:1478818. doi: 10.3389/fendo.2024.1478818. eCollection 2024.
4
Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study.伊朗具有种族和基因多样性的成年人群中代谢功能障碍相关脂肪性肝病的患病率及特征：PolyIran-肝脏研究结果
Middle East J Dig Dis. 2024 Apr;16(2):86-95. doi: 10.34172/mejdd.2024.374. Epub 2024 Apr 30.
5
Does Autophagy have a Role in the Pathogenesis of Pediatric Hepatic Steatosis?自噬在小儿肝脂肪变性发病机制中的作用
Asian Pac J Cancer Prev. 2024 May 1;25(5):1753-1761. doi: 10.31557/APJCP.2024.25.5.1753.
6
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease.肝硬化的代偿：揭开非酒精性脂肪性肝病的自然史演变。
Nat Rev Gastroenterol Hepatol. 2024 Jan;21(1):46-56. doi: 10.1038/s41575-023-00846-4. Epub 2023 Oct 5.
7
Disruption of brain regional homogeneity and functional connectivity in male NAFLD: evidence from a pilot resting-state fMRI study.男性非酒精性脂肪性肝病脑区局部一致性和功能连接的破坏：一项静息态 fMRI 初步研究的证据。
BMC Psychiatry. 2023 Aug 29;23(1):629. doi: 10.1186/s12888-023-05071-6.
8
Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus.非传统血脂指标对非肥胖型2型糖尿病患者代谢功能障碍相关脂肪性肝病的预测价值
Diabetes Metab Syndr Obes. 2023 Aug 7;16:2345-2354. doi: 10.2147/DMSO.S418020. eCollection 2023.
9
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy.线粒体代谢功能障碍与非酒精性脂肪性肝病：从发病机制到临床靶向治疗的新见解。
J Transl Med. 2023 Jul 28;21(1):510. doi: 10.1186/s12967-023-04367-1.
10
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.关于代谢功能障碍相关脂肪性肝病与慢性肾脏病风险的国际德尔菲共识声明
Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):386-403. doi: 10.21037/hbsn-22-421. Epub 2023 Feb 23.